Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof

US11884744B2 · kind B2 · utility

Assignees

• Boehringer Ingelheim International GmbH · DE
• Macrogenics, Inc. · US

Inventors

• Sanjaya Singh · Sandy Hook, US
• Qi Pan · Chappaqua, US
• Rachel Rebecca Barrett · Bethel, US
• Leslie S. Johnson · Travilah, US
• Pankaj Gupta · Scarsdale, US
• Sarah Low · Carmel, US
• Haixia Wu · Danbury, US

Key dates

• Filing date: Oct 22, 2020
• Grant date: Jan 30, 2024
• Expiry date: Apr 25, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12P21/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The disclosure relates to compounds specific for IL23A and BAFF, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.